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Abstract There is evidence for a role for calciumlcalmodulin- 
dependent protein pbosphorylation in regulation of insulin secre- 
tion but the molecular nature of the kinase(s) responsible is un- 
known. In this study, the screening of a neonatal rat islet cDNA 
library resulted in the isolation of a 2 kb clone that was 99% 
homologous to the p’ isoform of calciumlcahuodulin-dependent 
protein kinase II. The predicted 589 amino acid sequence with a 
calculated mass of 64,976 Da contained a 24 amino acid deletion 
in addition to the 15 amino acid deletion that differentiates the 
p’ from the p isoform, and included an 86 amino acid novel 
domain consisting of a tandem repeat of proline-rich residues. The 
expression of this new isoform of calciumlcalmodulin-dependent 
protein kinase II (&) was confirmed in p-cell lines and testis by 
DNA amplification of the sequence encoding the inserted domain 
by reverse transcriptase-polymerase chain reaction, followed by 
Southern analysis. 
K~JI ~vords: CaM kinase II; Insulin secretion; Protein 
phosphorylation; P-cell 
1. Introduction 
It is well established that insulin secretagogues such as glu- 
cose, which lead to an increase in intracellular Ca2+ via depolar- 
ization of thep-cell, are able to initiate insulin release [l]. There 
is growing evidence that a calcium/calmodulin-dependent pro- 
tein kinase (CaM kinase), the activity of which has been de- 
tected in association with the cytoskeleton in isolated pancre- 
atic islets [2,3], plays an important role in glucose-regulated 
insulin secretion. That inhibition of /?-cell CaM kinase results 
in inhibition of insulin release has been demonstrated in pancre- 
atic islets with the use of the diabetogenic agent, alloxan, and 
its analogue, dehydrouramil[4,5] and at the single cell level with 
a specific peptide inhibitor of CaM kinase [6]. The activation 
of islet CaM kinase has been shown to exhibit a close correla- 
tion with glucose-induced insulin secretion [7]. It has been sug- 
gested that P-cell CaM kinase may be similar or identical to 
CaM kinase 11 [8]. This multifunctional protein kinase, al- 
though predominantly expressed in neurons, is present in a 
variety of mammalian tissues and has been implicated in the 
regulation of multiple cellular processes, including contractil- 
ity, and neurotransmitter release and synthesis [9,10]. CaM 
kinase II is a multimer of 4412 subunits [ 10,111, each containing 
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a catalytic, a regulatory and an association domain. The asso- 
ciation domain is believed to be required for the assembly of 
subunits and for specific targeting to subcellular locations. Mo- 
lecular cloning indicates that at least four distinct genes encode 
CaM kinase II isoforms, designated as a. p, y and 6. Alterna- 
tively spliced variants of each subunit, which differ in insertions 
or deletions between the calmodulin binding site in the regula- 
tory domain and the association domain, are expressed in dif- 
ferent tissues [l l-161, suggesting specific functional roles for 
each isoform. A sequence inserted in the variable domain of 6, 
CaM kinase II appears to be responsible for its nuclear target- 
ing [17]. The y and 6 subunits appear to be the predominant 
forms in peripheral tissues, and although the a and p/p 
isoforms have only been cloned from neural tissues, B-subunit- 
specific mRNA species have also been detected in skeletal mus- 
cle, diaphragm, small intestine and testis [18]. 
In this study we present conclusive evidence that /?-cells ex- 
press CaM kinase II. We report here the cloning from rat 
pancreatic islets of a novel isoform of CaM kinase II that we 
designate as p3 that appears to be the product of alternative 
splicing of the P-subunit gene transcript. This is the first time 
that a p-isoform of CaM kinase II has been cloned from a 
non-neuronal source. 
2. Materials and methods 
2. I. Isolation and sequencing oj cDNA clones 
A neonatal rat islet cDNA library constructed in pCDM8 (InVitro- 
gen) was screened using random-primer “P-labelled probes corre- 
sponding to two contiguous EcoRI-BsaHI restriction fragments (730 
and 815 bp) of a cDNA clone of mouse brain CaM kinase II a-subunit. 
Eleven putative CaM kinase clones were Isolated after three rounds of 
screening, and subcloned into pBluescript (Stratagene). The 5’ and 3’ 
ends of three clones were sequenced by the dideoxynucleotide chain 
termination method [19] using Sequenase 2.0 (US Biochemicals). Two 
clones had identical nucleotide composition and the third consisted of 
an internal fragment that was 100% homologous to the CaM kinase II 
/?-subunit. The sequence of both strands of one of the clones, encom- 
passing the entire CaM kinase II coding region, was determined and 
compared to DNA sequences of the cloned CaM kinase II isoforms 
using the University of Wisconsin Genetic Computers Group software 
package [20]. 
2.2. Reverse transcription und polymeruse chain reaction 
Total RNA was purified from rat tissues andb-cell lines [21] and used 
for reverse transcription-polymerase chain reaction (RT-PCR) [22] with 
Moloney murine leukemia virus reverse transcriptase (Life Technolo- 
gies) and the antisense primer complementary to nucleotides 1413.-1434 
of B, CaM kinase II. One twentieth of the volume of the reverse tran- 
schption reactions was subjected to amplification with the sense primer, 
corresponding to nucleotides 1131~1154 of B, CaM kinase II and the 
antisense primer (primer pair I, each primer included BamHI sites and 
4 extra nucleotides at their 5’ ends). Coding regions of rat brain CaM 
kinase cloned subunits a and p, and y. were amplified with the sense 
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primer 5’-ATGGCTACCATCACCTGCACC-3’ and the antisense 
primer 5’-TCAATGCGGCAGGACGGAGG-3’ (mimer uair II). The 
of rat brain /?’ CaM kinase II [12] with the exceptions of a 72 
nucleotide deletion (24 amino acids) corresponding to residues 
947-1019, which is also found in the ~1, 6 and some of the y 
isoforms, and a 258 nucleotide insertion (86 amino acids) at 
position 1227 of the brain enzyme, suggesting that both mes- 
sages originate from alternative splicing of the p-isoform gene 
transcript. The clone encodes a predicted protein of 589 amino 
acids with a calculated molecular mass of 64,975 Da. The only 
substitution between the two sequences consists of a change 
from valine at position 3 17 of the/Y CaM kinase II to alanine, 
as a result of the splicing event occurring within the GTG 
codon at position 946. The 86 amino acid insertion in the 
association domain (corresponding to nucleotides 1155-1412 in 
the /$ CaM kinase II) comprises two repeated motifs of 43 
amino acids each, in a tandem arrangement which are 84% 
identical (Fig. 2). Proline accounts for 27% of the residues in 
this domain, and 48% of the sequence is hydrophobic. The 
second repeat motif contains the peptide PPVGPPPCP (amino 
acids 436-444) that conforms to the consensus sequences PX- 
XXPPXXP/PXXPPXXP derived from the alignment of puta- 
tive SH3 (src homology 3) domain-binding sites that are present 
in dynamin, 3BP1, mSOS1 [25], and in SPRK [26]. A potential 
CaM kinase II phosphorylation site (consensus RXXSIT) is 
present in the sequence RRGS (residues 42&427). The search 
for motifs in the Prosite dictionary of protein sites revealed that 
the novel domain provides 4 additional potential protein kinase 
C phosphorylation sites in serines 379, 413, 422 and 456. 
a, CaM kinase II clone was amplified using the sense phmer 5’-AG- 
CCCAATCGCCACCGCCATG-3’ (nucleotides 2747) and the anti- 
sense primer 5’-ACTCTGTCCGGTGAAACCAGGCG-3’ (comple- 
mentary to nucleotides 1821-1843) (primer pair III). Thirty cycles of 
amplification were conducted with one unit of Vent DNA polymerase 
per reaction (New England Biolabs) in the reaction buffer supplied by 
the manufacturers. Each cycle consisted of a I-min denaturation at 
94”C, 45-s annealing at 58”C, and 90-s extension at 73°C. A negative 
control that lacked template was included for every set of PCR reac- 
tions. 
2.3. Southern analysis 
PCR products electrophoresed in an agarose gel were transferred and 
UV fixed onto a nylon membrane (Hybond N; Amersham). Hybridiza- 
tion was carried out at 42°C with a BamHI-HincII restriction fragment 
(nucleotides 1081-1460) of p3 CaM kinase II) that had been Klenow 
filled-in with [“P]dCTP. After hybridization, the membrane was 
washed twice with 0.1 x SSC, 0.1% SDS at 65°C for 1 h and subjected 
to autoradiography. 
2.4. Sequence homology searches 
Database searches were conducted with the MPsrch program against 
the Swiss-Prot protein sequence database using the best local similarity 
algorithm [23]; with BLAST [24] against Brookhaven Protein Data 
Bank, PIR, Swiss-Prot and the SBASE protein domain database; and 
with Motifs [20] against the PROSITE dictionary of protein sites. 
3. Results 
3.1. Nucleotide and deduced amino acid sequence of rat islet 
CaM kinase II (pj isoform) 
Sequencing of the 5’ and 3’ ends of two of the 11 putative 
CaM kinase cDNA clones obtained by screening a neonate rat 
islet library showed that one clone (1979 base pairs) encom- 
passed the entire coding region. Analysis of the nucleotide 
sequence (Figs. 1 and 2) revealed that it was identical to that 
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Fig. I Nucleotide and deduced amino acid sequence of thepi isoform of CaM kinase Il. The proline-rich insertion is boxed. The putative CaM kinase 
3.2. Evidence ji)r expression of the inserted domain in the B-cell 
by RT-PCR 
Total RNA from various tissues and culturedp-cell lines was 
reverse transcribed and then amplified by PCR with primers 
flanking the 258 nucleotide insertion. Amplified products of 
II phosphorylation site is underlined and the putative SH3-binding site is shaded. 
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Fig. 2. Comparison of the variable and association domains of three 
isoforms of the /? subunit of CaM kinase II. Solid narrow boxes repre- 
sent deletions. The number of amino acids in each conserved, deleted 
or inserted region is indicated above the pj isoform. The amino acid 
composition of the proline-rich insertion in the/?, isoform (shaded box) 
is depicted in the lower panel as an internal alignment of the two 
43-residue halves of the fragment, where identical repeats are boxed. 
The numbers on each side of the alignment correspond to positions in 
the /?? deduced amino acid sequence (Fig. 1). 
compatible size with that of the sequence encoding the extra 
domain plus the primer sequences (324 bp) were obtained with 
cDNA from HIT T15 and MIN6/?-cell lines, and from neonatal 
rat islets and adult rat testis (Fig. 3A). However, no amplifica- 
tion products of this size were detected with reverse transcrip- 
tion products from brain, heart, small intestine, kidney or liver 
RNA. To confirm the identity of the PCR products, an end- 
labelled /I1 CaM kinase II BumHI-HincII restriction fragment 
(nucleotides 1081-1460) was used in Southern analysis. In 
order to assess whether primer sequences in the amplified frag- 
ments could account for a positive signal, sequences corre- 
sponding to the coding regions of brain CaM kinase II isoforms 
u, p and y, and ofp, CaM kinase II were amplified from cDNA 
clones and included in the Southern blot as hybridization con- 
trols. The results shown in Fig. 3B indicate that a variant of 
CaM kinase II containing the novel domain described in this 
study is expressed in both the /?-cell lines and also in testis. 
4. Discussion 
There is growing evidence for the importance for insulin 
secretion of calcium/calmodulin-dependent protein phospho- 
rylation in the P-cell [4-71. Studies on the substrate specificity 
[7,8] and sensitivity to inhibitors [4,.5,27] of CaM kinase activity 
in islets of Langerhans led to the suggestion that the enzyme 
may be similar or identical to CaM kinase II [8]. Immunological 
evidence has supported this possibility [7,28] but the/I-cell CaM 
kinase II has not hitherto been characterised at the molecular 
level. In the present study we provide conclusive evidence for 
the expression of CaM kinase 11 in the pancreatic p-cell by 
molecular cloning of a novel isoform (/&) of the enzyme. In 
contrast to previously cloned CaM kinase II isoforms, in which 
the differences lie mainly in the variable domain, the major 
distinguishing feature of the cloned islet CaM kinase II is an 
86 amino acid insertion containing two tandem repeats in the 
association domain. 
Database searches conducted in order to predict a structure- 
function relationship of the novel repeated motif resulted in 
significant homologies with proline-rich regions (PRRs). Pro- 
line-rich sequences containing multiple tandem repeats with 
minor variations have been implicated in the reversible associ- 
ation of proteins into functional complexes regulated by phos- 
phorylation within the PRR [29]. An example is provided by 
the synaptic vesicle-associated protein synapsin I, which con- 
tains three 17-residue proline-rich repeats. Phosphorylation of 
two serines in the PRR near the C-terminal region of synapsin 
I by CaM kinase II causes synapsin I to dissociate from synap- 
tic vesicles [30] and increases neurotransmitter release [3 1,321; 
and the regulatory domain of a synaptic vesicle-associated form 
of CaM kinase 11 binds the C-terminal region of synapsin I [33]. 
Apart from the synapsins, several other substrates for CaM 
kinase II, such as calcineurin, cardiac ryanodine receptor and 
microtubule-associated proteins [lo]. exhibit homologies with 
the /?X proline-rich domain. It is tempting to speculate that the 
PRR of the p3 isoform, and the putative SH3-binding sequence 
contained within, play a role in the interaction of 8, CaM 
kinase II with signalling pathway or cytoskeleton components, 
according to the targeting subunit hypothesis [34]. This hypoth- 
esis postulates that a part of a protein kinase directs the cata- 
lytic domain to a target locus, and is exemplified by the pres- 
ence of a nuclear localization signal in an 11 -amino acid insert 
at the beginning of the association domain of the 6, isoform 
of CaM kinase 11 [17]. 
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Fig. 3. Expression of the sequence coding for the 86 amino acid inser- 
tion of CaM kinase II #?l isoform. (A) PCR products obtained with 
primer pair II (cDNA clones of brain CaM kinase isoforms) (lanes 2 5): 
with primer pair III (lane 6); and with primer pair I, flanking the 258 
bp insertion (RT-PCR) (lanes 9- 12) as described in section 2. Lane 2, 
mouse a-subunit; lane 3, rat a-subunit; lane 4, ratp-subunit; lane 5. rat 
y-subunit. Lane 6, p, CaM kinase II; lane 9, HIT Tl5 ,%cells; lane IO, 
MIN 6 B-cells; lane 11, rat testis; lane 12, rat islets. Lanes I and 7. 
lambda HindIII-EcoRI markers; lanes 8 and 13 DNA ladder. The 
numbers on each side indicate the size of DNA markers in base pairs. 
(B) Southern blot of the products shown in A with an end-labelled 
probe consisting of nucleotides 1081-1460 of the ,8, CaM kinase II. 
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Expression of the /3-isoform of CaM kinase II has previously 
been regarded as confined to the nervous system [17]. The & 
isoform appears to be derived by alternative splicing of the 
same primary transcript as the /I form. Our results with RT- 
PCR on various tissues suggest that the splicing event giving 
rise to the p3 form has a restricted tissue distribution. It should 
also be noted that although two independent clones isolated 
from the rat islet cDNA library corresponded to the B-subunit, 
there is no evidence for that to be the only or even the predom- 
inant isoform of the enzyme in thep-cell. It has been shown that 
the level of /I message decreases during neuronal development 
and that the a :/I ratio in forebrain increases more than twofold, 
the P-subunit being the dominant isozyme at birth [lo]. These 
facts may therefore account for a higher probability of isolating 
clones of the /I isoform from the neonatal rat islet library. 
Expression of the cloned /I3 isoform and studies on subcellu- 
lar localization of the enzyme will contribute to the understand- 
ing of structure-function relationships. 
Acknowledgements: This study has been supported by grants from the 
Medical Research Council, the British Diabetic Association and the 
Wellcome Trust. We thank Dr. B. Michelsen, Hagedorn Research Insti- 
tute, Gentofte, Denmark, for the rat islet cDNA library; Profs. A.R. 
Means, Duke University, Durham, NC, USA, and H. Fujisawa, Asa- 
hikawa Medical College, Japan, for the CaM kinase II cDNA clones; 
and Profs. J.-I. Miyazaki, University of Tokyo and A.E. Boyd III, Tufts 
University, Boston, for the /I-cell lines MIN6 and HIT T15, respec- 
tively. 
References 
PI 
PI 
[31 
141 
151 
[61 
[71 
[81 
[91 
Ashcroft, S.J.H. and Ashcroft, F.M. (1992) Insulin: Molecular 
Biology to Pathology, pp. 97-150, IRL Press, Oxford. 
Harrison, D.E. and Ashcroft, S.J.H. (1982) Biochim. Biophys. 
Acta 714, 313-319. 
Ashcroft, S.J.H. and Hughes, S.J. (1990) Biochem. Sot. Trans. 18, 
116118. 
Colca, J.R., Kotogal, N., Brooks, C.L., Lacy, P.E., Landt, M. and 
McDaniel, M.L. (1983) J. Biol. Chem. 258, 726&7263. 
Harrison, D.E., Poje, M., Rocic, B. and Ashcroft, S.J.H. (1986) 
Biochem. J. 237, 191-196. 
Ammall, C., Eliasson, L., Bokvist, K., Larsson, O., Ashcroft, 
F.M. and Rorsman, P. (1993) J. Physiol. 472, 6655689. 
Wenham, R.M., Landt, M. and Easom, R.A. (1994) J. Biol. Chem. 
269, 49474952. 
Hughes, S.J., Smith, H. and Ashcroft, S.J.H. (1993) Biochem. J. 
289, 7955800. 
Colbran, R.J. and Soderling, T.R. (1990) Curt-. Topics Cell. Regul. 
31, 181-221. 
K Urquidi, S.J. H. AshcroftlFEBS Letters 358 (1995) 23-26 
[lo] Hanson, P.I. and Schulman, H. (1992) Annu. Rev. Biochem. 61, 
5599601. 
[ll] Zhou, Z.L. and Ikebe, M. (1994) Biochem. J. 299, 489495. 
[l2] Bulleit, R.F., Bennett, M.K., Molloy, S.S., Hurley, J.B. and 
Kennedy, M.B. (1988) Neuron 21, 63-72. 
[13] Nghiem, P., Saati, S.M., Martens, CL., Gardner, P. and 
Schulman, H. (1993) J. Biol. Chem. 268, 5471-5479. 
[14] Schworer, CM., Rothblum, L.I., Thekkumkara, T.J. and Singer, 
H.A. (1993) J. Biol. Chem. 268, 14443314449. 
[I51 Edman, CF. and Schulman, H. (1994) Biochim. Biophys. Acta 
1221, 89-101. 
[16] Mayer, P., Miihlig, M., Schatz, H. and Pfeiffer, A. (1994) Biochem. 
J. 298, 7577758. 
[17] Srinivasan. M.. Edman. CF. and Schulman. H. (1994) J. Cell Biol. 
[I81 
[191 
1201 
[211 
[221 
126, 839-852. 
\ , 
Tobimatsu, T. and Fujisawa, H. (1989) J. Biol. Chem. 264, 179077 
17912. 
[231 
[241 
~251 
[261 
~271 
[281 
[291 
[301 
1311 
[321 
I331 
[341 
Sanger, G., Nicklen, S. and Coulson, A.R. (1977) Proc. Nat]. 
Acad. Sci. USA 74, 5463-5467. 
Devereux, J., Haeberli, P. and Smithies, 0. (1984) Nucleic Acids 
Res. 12, 387-395. 
Chirgwin, J.J., Przbyla, A.E., Mac Donald, R.J. and Rutter, W.J. 
(1979) Biochemistry 18, 52945299. 
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular 
Cloning: A Laboratory Manual. Cold Spring Harbour Laboratory 
Press, New York. 
Smith, T.F. and Waterman, M.S. (1981) J. Mol. Biol. 147, 1955 
197. 
Altschul, S.F., Gish, W., Miller, W., Myers, E.W. and Lipman, 
D.J. (1990) J. Mol. Biol. 215, 403410. 
Gout, I., Dhand, R., Hiles, I.D., Fry, M.J., Panayotou, G., Das, 
P., Truong, 0.. Totty, N.F., Hsuan, J., Booker, G.W., Campbell, 
I.D. and Waterfield, M.D. (1993) Cell 75, 25-36. 
Gallo, K.A., Mark, M.R., Scadden, D.T., Wang, Z., Gu, Q. and 
Godowski, P.J. (1994) J. Biol. Chem. 269, 15092~15100. 
Wenham, R.M., Landt, M., Walters, SM., Hidaka, H. and 
Easom, R.A. (1992) Biochem. Biophys. Res. Commun. 189, 128- 
133. 
Niki, I., Okazaki, K., Saitoh, M., Niki, A., Niki, H., Tamagawa, 
T., Iguchi, A. and Hidaka, H. (1993) Biochem. Biophys. Res. 
Commun. 191, 255-261. 
Williamson, M.P. (1994) Biochem. J. 297, 2499260. 
Schiebler, W., Jahn, R., Doucet, J.-P., Rothlein, J. and Greengard, 
P. (1986) J. Biol. Chem. 261, 8383-8390. 
Nichols, R.A., Sihra, T.S., Czernik, A.J., Nairn, A.C. and Green- 
gard, P. (1990) Nature 343, 647-651. 
Llinas, R., MC Guiness, T.L., Leonard, C.S., Sugimori, M. and 
Greengard, P. (1985) Proc. Nat]. Acad. Sci. USA 82, 303553039. 
Benfenati, F., Valtorta, F., Rubenstein, J.L., Gorelick, F.S., 
Greengard, P. and Czernik, A.J. (1992) Nature 359, 417420. 
Hubbard, M.J. and Cohen, P. (1993) Trends Biochem. Sci. 18. 
172-177. 
